Details
PROGRAM DESCRIPTION
This session will discuss key differences in the pharmacologic profiles of various oral chronic anticoagulation agents that influence treatment selection for individual patients with atrial fibrillation who are at risk of stroke.
FORMAT OPTIONS
Streaming Online Video:
Instant access! Place your order. Receive a welcome email and you're ready to go. No waiting!
View your videos. Complete your evaluation. Print your certificate. It's that easy!
To access videos:
- Log in to APEA CE Center or download APEA's free mobile app
- Download or stream your course videos and course manual
- Complete the quiz and evaluation and earn your credits!
*Please note: Videos require the Google Chrome browser.*
Written course material and evaluation MUST be accessed within 6 months after purchase.
LEARNING OBJECTIVES
After taking part in this educational activity, participants will be able to:
- Review evidence-based scoring assessment to risk stratify adults with A Fib while considering stroke and bleeding risks
- Compare and contrast pharmacologic profiles of the options for chronic oral anticoagulants that influence the selection of a specific agent for an individual patient with chronic atrial fibrillation
- Discuss starting and target dosing options for oral anticoagulant therapy for adults with atrial fibrillation, including those with kidney or liver impairment and other patient-related factors
- Review drug-drug interactions related to various chronic anticoagulation treatment options
- Discuss patient teaching related to use of various chronic anticoagulation including monitoring drug levels as appropriate and possible drug-food interactions
TIME TO COMPLETE
2 hours
Each video is accessible twice within six months of purchase.
CREDITS
NPACE designates this educational activity for a maximum of 1.5 CNE credit(s), of which 1.5 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
RELEASED
February 2021; Reviewed February 2022
DISCLAIMER
NPACE aims to provide up-to-date and accurate research and information in all of their programming. Given that so much information in medicine rapidly changes and is dynamic – we recognize that new research, advisements for practice and clinical guidelines can become available on a daily basis. Learners are advised to carefully consider the date of on-demand content and consult further sources of information prior to utilizing and applying the clinical information discussed in this session.
ACCREDITED PROVIDER
Program ID: 20CAAFI
Provider Accreditation Statement
This program is provided by Nurse Practitioner Associates for Continuing Education (NPACE).
Nurse Practitioner Associates for Continuing Education (NPACE) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
In addition to ANCC, NPACE is approved as a provider of continuing education in nursing by: the California Board of Registered Nursing, Provider Number CEP8720 and Florida CE Broker #50-1476.
NPACE, the Provider of awarding contact hours, is responsible for adherence to ANCC criteria.
FACULTY
This course is taught by Leslie L. Davis, PhD, RN, ANP-BC, FAANP, FACC, FAHA, FPCNA. Dr. Davis is an Associate Professor of Nursing at the University of North Carolina at Chapel Hill, School of Nursing, PhD Division as well as a part-time NP with the Cardiology Division at UNC. She is an AANP, ACC and AHA fellow. Leslie L. Davis has disclosed no relevant financial relationships.
APEA App
APEA Mobile is a free app for Apple and Android devices. Purchases must be made through apea.com and will automatically be synced to your app. Content downloaded to your device from the app can be accessed at any time, even without an internet connection.
Minimum space required: Each video section may take up to 150 MB. Each audio section may take up to 90 MB. Requires iPhone versions 5 and above and iPad Air and Mini and above.